ISOO Virtual 2024
Mentored Case Presentations with Structured Discussion, Keynote Lectures
Saturday - Sunday, January 6 – 7, 2024
Saturday, January 6
Session 1, Intraocular Tumors – Melanoma and other Uveal Tumors
2:00 PM UTC to 4:00 PM UTC
Session 1, Intraocular Tumors – Retinoblastoma and other Retinal Tumors
4:00 PM UTC to 6:00 PM UTC
New York, USA (Eastern Time): 10:00 AM
Chicago, USA (Central Time): 9:00 AM
Denver, USA (Mountain Time): 8:00 AM
Los Angeles, USA (Pacific Time): 7:00 AM
London, UK (Greenwich Mean Time): 2:00 PM
Berlin, Germany (Central European Time): 3:00 PM
Paris, France (Central European Time): 3:00 PM
Madrid, Spain (Central European Time): 3:00 PM
Lagos, Nigeria (West Africa Time): 3:00 PM
Cairo, Egypt (Eastern European Time): 4:00 PM
Mumbai, India (Indian Standard Time): 7:30 PM
Beijing, China (China Standard Time): 8:00 PM
Tokyo, Japan (Japan Standard Time): 10:00 PM
Sydney, Australia (Australian Eastern Standard Time): 12:00 AM (next day)
Sunday, January 7
Session 1, Ocular Surface and Eyelid Tumors
10:00 AM UTC to 12:00 Noon UTC
Session 2, Orbital and Optic Nerve Tumors and Miscellaneous
12:00 Noon UTC to 2:00 PM UTC
New York, USA (Eastern Time): 6:00 AM
Chicago, USA (Central Time): 5:00 AM
Denver, USA (Mountain Time): 4:00 AM
Los Angeles, USA (Pacific Time): 3:00 AM
London, UK (Greenwich Mean Time): 10:00 AM
Berlin, Germany (Central European Time): 11:00 AM
Paris, France (Central European Time): 11:00 AM
Madrid, Spain (Central European Time): 11:00 AM
Lagos, Nigeria (West Africa Time): 11:00 AM
Cairo, Egypt (Eastern European Time): 1:00 PM
Mumbai, India (Indian Standard Time): 3:30 PM
Beijing, China (China Standard Time): 5:00 PM
Tokyo, Japan (Japan Standard Time): 7:00 PM
Sydney, Australia (Australian Eastern Standard Time): 8:00 PM
Guidelines for Abstract Submission
Submit abstracts online on the Google form https://forms.gle/jrgkKtBrtUoXBxQ17
Abstracts for case presentation are invited.
Cases with intriguing clinical presentation, interesting imaging findings, novel management modalities, unique pathology, challenging complications or simply a robust teaching point are appreciated.
One of the authors must be an ISOO member.
One presenting author can submit a maximum of three abstracts, but each abstract should be in a different category. Strictly only one abstract in each category.
Abstracts should be limited to 2000 characters (including spaces) and should be structured under the following headings: Introduction/Purpose, Case Report, Conclusion, Clinical Implication
Categories: Eyelid Tumors, Ocular Surface Tumors, Uveal Tumors, Retinal Tumors, Orbital and Optic Nerve Tumors
Cases, if selected, should be presented in 5 minutes, followed by expert comments and a panel discussion.
A copy of the complete presentation of the selected case in PDF format should be submitted to enable discussion.
Best cases in each session will receive an Award.
Timelines
Abstract submission opens November 5
Abstract submission closes December 5
Announcement of abstract selection on December 25
Submission of the complete presentation in PDF format by December 25